Pivotal phase III trial investigating galactomannan-C (DAVANAT) in combination with standard chemotherapy in patients with metastatic colorectal cancer.

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 15 May 2012

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

15 May 2012 This rial does not appear to have begun in 2011 as planned.
11 Jan 2011 Agreement for the design of this pivotal trial has been reached between the US FDA and Pro-Pharmaceuticals.
11 Jan 2011 Planned initiation date changed to 1 Jan 2011, based on information in a media release from Pro-Pharmaceuticals.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com